Literature DB >> 25940656

Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min).

.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25940656     DOI： 10.1093/ndt/gfv100

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  39 in total

Review 1.  [Diabetic kidney disease - Update 2016].

Authors:  Harald Sourij; Roland Edlinger; Friedrich Prischl; Martin Auinger; Alexandra Kautzky-Willer; Marcus D Säemann; Rudolf Prager; Martin Clodi; Guntram Schernthaner; Gert Mayer; Rainer Oberbauer; Alexander R Rosenkranz
Journal:  Wien Klin Wochenschr       Date:  2016-04       Impact factor: 1.704

2.  Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort.

Authors:  Solène M Laville; Marie Metzger; Bénédicte Stengel; Christian Jacquelinet; Christian Combe; Denis Fouque; Maurice Laville; Luc Frimat; Carole Ayav; Elodie Speyer; Bruce M Robinson; Ziad A Massy; Sophie Liabeuf
Journal:  Br J Clin Pharmacol       Date:  2018-09-24       Impact factor: 4.335

3.  Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease.

Authors:  Jinnie J Rhee; Jialin Han; Maria E Montez-Rath; Sun H Kim; Mark R Cullen; Randall S Stafford; Wolfgang C Winkelmayer; Glenn M Chertow
Journal:  J Diabetes Complications       Date:  2019-09-03       Impact factor: 2.852

Review 4.  Chronic Kidney Disease Diagnosis and Management: A Review.

Authors:  Teresa K Chen; Daphne H Knicely; Morgan E Grams
Journal:  JAMA       Date:  2019-10-01       Impact factor: 56.272

Review 5.  Hyperkalemia in the Hypertensive Patient.

Authors:  Jay Ian Lakkis; Matthew R Weir
Journal:  Curr Cardiol Rep       Date:  2018-03-01       Impact factor: 2.931

6.  Sustained low-efficiency dialysis for metformin-associated lactic acidosis in patients with acute kidney injury.

Authors:  Paolo Greco; Giuseppe Regolisti; Umberto Maggiore; Elena Ferioli; Filippo Fani; Carlo Locatelli; Elisabetta Parenti; Caterina Maccari; Ilaria Gandolfini; Enrico Fiaccadori
Journal:  J Nephrol       Date:  2018-12-06       Impact factor: 3.902

7.  Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.

Authors:  Clement Lo; Tadashi Toyama; Megumi Oshima; Min Jun; Ken L Chin; Carmel M Hawley; Sophia Zoungas
Journal:  Cochrane Database Syst Rev       Date:  2020-07-30

Review 8.  Deleting Death and Dialysis: Conservative Care of Cardio-Vascular Risk and Kidney Function Loss in Chronic Kidney Disease (CKD).

Authors:  Raymond Vanholder; Steven Van Laecke; Griet Glorieux; Francis Verbeke; Esmeralda Castillo-Rodriguez; Alberto Ortiz
Journal:  Toxins (Basel)       Date:  2018-06-12       Impact factor: 4.546

9.  Antidiabetic and Other Therapies Used in Subjects with Diabetes and Chronic Kidney Disease in a Hospital-Based Clinic Population in Greece.

Authors:  Ilias N Migdalis; Nikolaos Papanas; Ioannis M Ioannidis; Alexios E Sotiropoulos; Athanasios E Raptis; George D Dimitriadis
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

Review 10.  Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

Authors:  Clement Lo; Tadashi Toyama; Ying Wang; Jin Lin; Yoichiro Hirakawa; Min Jun; Alan Cass; Carmel M Hawley; Helen Pilmore; Sunil V Badve; Vlado Perkovic; Sophia Zoungas
Journal:  Cochrane Database Syst Rev       Date:  2018-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.